Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8

Assignee

• Shionogi & Co.
• Osaka University

Inventors

• Tetsuya Yoshida (4 patents)
• Yujiro Kidani (3 patents)
• Mitsunobu Matsumoto (2 patents)
• Takayuki Kanazawa (2 patents)
• Satomi Shinonome (2 patents)
• Kanji Hojo (2 patents)
• Naganari Ohkura (3 patents)
• Shimon Sakaguchi (9 patents)
• Atsushi Tanaka (10 patents)
• Hisashi Wada (3 patents)
• Atsunari Kawashima (2 patents)
• Norio Nonomura (5 patents)

View full patent text on Google Patents →